Pell Bio-Med Technology Co., Ltd. (6949)の価格はいくらですか

Pell Bio-Med Technology Co., Ltd. (6949)の価格は$47.38です

Pell Bio-Med Technology Co., Ltd. (6949)の時価総額は何ですか

Pell Bio-Med Technology Co., Ltd. (6949)の時価総額は$3.11Bです

Pell Bio-Med Technology Co., Ltd.（6949）株式分割

Pell Bio-Med Technology Co., Ltd., established in 2017 and headquartered in Taipei, Taiwan, operates as a biomedical firm specializing in advanced cell culture technologies and methods for therapeutic applications. The company's commercial portfolio encompasses good tissue practice (GTP) laboratory infrastructure, adipose-derived stem cells (ADSC) utilized in regenerative medicine, and both CIK and DC-CIK therapies aimed at combating various cancers. Beyond its existing products, Pell Bio-Med is actively engaged in developing novel pharmaceuticals for diverse cancer types, pioneering cell immunotherapy strategies, and advancing stem cell regenerative therapy techniques. Its research and development efforts extend to cutting-edge areas such as chimeric antigen receptor T cell (CAR-T), CAR-NK, CAR-?dT, and genetically modified ADSC technologies. The company is also progressing product development specifically targeting indications like B-cell non-Hodgkin lymphoma (B-NHL), ovarian cancer, multiple myeloma, and thyroid cancer.